KSU presents Phoreus:
Phoreus Biotechnology, Inc. is the exclusive licensee of the Branched Amphipathic Peptide Capsule (BAPC) platform technology from the Kansas State University Research Foundation. This novel nanomaterial comprised of natural biodegradable amino acids has the capacity to improve the delivery capabilities of new vaccines, cancer therapies, alternative antibiotics, agricultural biopesticides and diagnostics. BAPC is licensed by Phoreus for commercialization in plant protection and nutrition, veterinary and medical applications.
Privately held, the company is headquartered within the Kansas Bioscience Park in Olathe, Kansas.